CDER/CBER Consolidation: Drug Center Structure Is Not Expected To Change

The Center for Drug Evaluation & Research expects that the assumption of product review responsibilities for biological products can be accomplished within its existing organizational framework

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet